Skip to main content
OpenTrials

Clinical trial condition

Amyloid Neuropathies

Explore clinical trials studying Amyloid Neuropathies. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Amyloid Neuropathies trial results

Recruiting

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

NCT04561518

Conditions
ATTR Amyloidosis, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +16 more
Locations
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Iowa City, Iowa, United States
View all 40 locations
View Trial Details
Recruiting

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06672237

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +23 more
Locations
  • Hospital Británico de Buenos Aires Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires (HIBA) Buenos Aires, Argentina
  • Hospital El Cruce San Juan Bautista, Argentina
  • Hospital das Clinicas da Universidade Estadual de Campinas (UNICAMP) Campinas, Brazil
View all 14 locations
View Trial Details
Completed

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

NCT01960348

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Orange, California, United States
  • Clinical Trial Site Denver, Colorado, United States
  • Clinical Trial Site Chicago, Illinois, United States
View all 52 locations
View Trial Details
Completed

A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation

NCT04201418

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more
Locations
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site San Diego, California, United States
  • Clinical Trial Site Aurora, Colorado, United States
  • Clinical Trial Site Farmington, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

NCT01705626

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +33 more
Locations
  • Klinikum Wels-Grieskirchen GmbH, Abteilung für Neurologie Wels, Austria
  • University of Pécs, Department of Neurology Pécs, Hungary
  • University of Szeged, Department of Neurology Szeged, Hungary
  • University Hospital Skopje, Department of Neurology Skopje, North Macedonia
View Trial Details
Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

NCT02319005

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +27 more
Locations
  • Clinical Trial Site Bakersfield, California, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
View all 61 locations
View Trial Details

Related conditions